Key points
- Biome to launch two new products in H1 FY27
- Products are two-month formats of top-selling Biome Daily and Biome Daily Kids
- Aimed at gastrointestinal symptoms, antibiotic side effects, and winter immune support
Full summary
Biome Australia Limited (ASX: BIO) is set to launch two new products in the first half of FY27: Biome Daily Probiotic 60 and Biome Daily Kids Probiotic 60. These two-month formats are designed to improve patient adherence and retention, as well as to increase transaction value for pharmacy partners. Both products are clinically supported and use microencapsulation technology to enhance the delivery of live bacteria to the gut. The new products will be supplied through existing pharmacy wholesalers and practitioner channels, spreading demand across more SKUs and reducing supply risks. These will also be Biome's first Australian-made products, manufactured under its onshore manufacturing agreement with Specialty Probiotics Australia.
Outlook
The company expects new sales to grow ahead of any substitution from the 30 packs, but does not provide specific revenue guidance for the new products.